Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more ...

Microscopic colitis, a form of inflammatory bowel disease, has no cure, but it's possible to enter remission. Learn more here ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...

Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Leading companies such as Pfizer, Abivax, and Reistone Biopharma are driving advancements in Ulcerative Colitis treatments to enhance patient care. LAS VEGAS , NV, UNITED STATES, January 16, 2025 /EI.

Leading companies such as Pfizer, Abivax, and Reistone Biopharma are driving advancements in Ulcerative Colitis treatments to enhance patient care. LAS VEGAS , NV ...